These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 36907321)

  • 1. AlphaFold, allosteric, and orthosteric drug discovery: Ways forward.
    Nussinov R; Zhang M; Liu Y; Jang H
    Drug Discov Today; 2023 Jun; 28(6):103551. PubMed ID: 36907321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Machine learning approaches in predicting allosteric sites.
    Nerín-Fonz F; Cournia Z
    Curr Opin Struct Biol; 2024 Apr; 85():102774. PubMed ID: 38354652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational Tools for Allosteric Drug Discovery: Site Identification and Focus Library Design.
    Huang W; Nussinov R; Zhang J
    Methods Mol Biol; 2017; 1529():439-446. PubMed ID: 27914066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AlphaFold, Artificial Intelligence (AI), and Allostery.
    Nussinov R; Zhang M; Liu Y; Jang H
    J Phys Chem B; 2022 Sep; 126(34):6372-6383. PubMed ID: 35976160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to.
    Carofiglio F; Trisciuzzi D; Gambacorta N; Leonetti F; Stefanachi A; Nicolotti O
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32937901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Druggable orthosteric and allosteric hot spots to target protein-protein interactions.
    Ma B; Nussinov R
    Curr Pharm Des; 2014; 20(8):1293-301. PubMed ID: 23713780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of allosteric targets in the discovery of safer drugs.
    Grover AK
    Med Princ Pract; 2013; 22(5):418-26. PubMed ID: 23711993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation Between Allosteric and Orthosteric Sites.
    Zhang W; Xie J; Lai L
    Adv Exp Med Biol; 2019; 1163():89-105. PubMed ID: 31707701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designed dualsteric modulators: A novel route for drug discovery.
    Li N; Zheng G; Fu L; Liu N; Chen T; Lu S
    Drug Discov Today; 2024 Oct; 29(10):104141. PubMed ID: 39168404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of protein allostery in rational anticancer drug design: an update.
    Nussinov R; Jang H
    Expert Opin Drug Discov; 2024 Sep; 19(9):1071-1085. PubMed ID: 39068599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
    An X; Lu S; Song K; Shen Q; Huang M; Yao X; Liu H; Zhang J
    J Chem Inf Model; 2019 Jan; 59(1):597-604. PubMed ID: 30525607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating Cryptic Pocket Discovery Using AlphaFold.
    Meller A; Bhakat S; Solieva S; Bowman GR
    J Chem Theory Comput; 2023 Jul; 19(14):4355-4363. PubMed ID: 36948209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AlphaFold accurately predicts distinct conformations based on the oligomeric state of a de novo designed protein.
    Cummins MC; Jacobs TM; Teets FD; DiMaio F; Tripathy A; Kuhlman B
    Protein Sci; 2022 Jul; 31(7):e4368. PubMed ID: 35762713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M; Hedderich JB; Kolb P; Hilger D
    Pharmacol Ther; 2022 Sep; 237():108242. PubMed ID: 35863587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric Methods and Their Applications: Facilitating the Discovery of Allosteric Drugs and the Investigation of Allosteric Mechanisms.
    Lu S; Shen Q; Zhang J
    Acc Chem Res; 2019 Feb; 52(2):492-500. PubMed ID: 30688063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Learning About Allosteric Drugs and Ways to Design Them.
    Wah Tan Z; Tee WV; Berezovsky IN
    J Mol Biol; 2022 Sep; 434(17):167692. PubMed ID: 35738428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of AlphaFold antibody-antigen modeling with implications for improving predictive accuracy.
    Yin R; Pierce BG
    Protein Sci; 2024 Jan; 33(1):e4865. PubMed ID: 38073135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into AlphaFold's breakthrough in neurodegenerative diseases.
    Mubeen H; Masood A; Zafar A; Khan ZQ; Khan MQ; Nisa AU
    Ir J Med Sci; 2024 Oct; 193(5):2577-2588. PubMed ID: 38833116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Computational Methods for the Rational Discovery of Allosteric Drugs.
    Wagner JR; Lee CT; Durrant JD; Malmstrom RD; Feher VA; Amaro RE
    Chem Rev; 2016 Jun; 116(11):6370-90. PubMed ID: 27074285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.